ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

A Clinical Trial to Determine the Long-term Safety and Tolerability of an Investigational Drug in People With Major Depressive Episode Associated With Bipolar I Disorder (Bipolar I Depression).

ClinicalTrials.gov ID: NCT05227209

Public ClinicalTrials.gov record NCT05227209. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 9:34 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 12-Month Open-label Extension Study to Evaluate the Long-term Safety, Tolerability, and Effectiveness of SEP-4199 Controlled Release (CR) for the Treatment of Major Depressive Episode Associated With Bipolar I Disorder (Bipolar I Depression)

Study identification

NCT ID
NCT05227209
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sumitomo Pharma America, Inc.
Industry
Enrollment
64 participants

Conditions and interventions

Interventions

  • SEP-4199 CR Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 16, 2022
Primary completion
Nov 16, 2023
Completion
Nov 16, 2023
Last update posted
Feb 20, 2025

2022 – 2023

United States locations

U.S. sites
25
U.S. states
14
U.S. cities
25
Facility City State ZIP Site status
University of Alabama at Birmingham Huntsville Regional Medical Campus Huntsville Alabama 35801
Advanced Research Center, Inc. Anaheim California 92805
Sun Valley Research Center Imperial California 92251
Clinical innovations, Inc. Riverside California 92506
Collaborative Neuroscience Research, LLC Torrance California 90502
Sarkis Clinical Trials Gainesville Florida 32607
Clinical Neuroscience Solutions, Inc. Jacksonville Florida 32256
Premier Clinical Research Institute, Inc Miami Florida 33122
Clinical Neuroscience Solutions, Inc. Orlando Florida 32801
Atlanta Behavioral Research, LLC Atlanta Georgia 30338
Psych Atlanta, P.C. Marietta Georgia 30060
AMR Conventions Research Warrenville Illinois 60555
St. Charles Psychiatric Associates / Midwest Research Group Saint Charles Missouri 63304
Alivation Research, LLC Lincoln Nebraska 68526
Center for Emotional Fitness Cherry Hill New Jersey 08002
Finger Lakes Clinical Research Rochester New York 14618
Richmond Behavioral Associates ERG Clinical Research - New York PLLC Staten Island New York 10312
New Hope Clinical Research Charlotte North Carolina 28211
Quest Therapeutics of Avon Lake Avon Lake Ohio 44012
Neuro-Behavioral Clinical Research, Inc North Canton Ohio 44720
Sooner Clinical Research Oklahoma City Oklahoma 73112
Lehigh Center for Clinical Research, LLC Allentown Pennsylvania 18104
Community Clinical Research, Inc. Austin Texas 78754
UTHealth Science Center at Houston Houston Texas 77054
Family Psychiatry of The Woodlands The Woodlands Texas 77381

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 44 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05227209, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 20, 2025 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05227209 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →